Cargando…
Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
PURPOSE: Dyslipidemia is a feature of polycystic ovary syndrome (PCOS) that may augment metabolic disturbances. Serum fatty acids are important biomedical indicators of dyslipidemia. The aim of this study was to determine the distinct serum fatty acids in various PCOS subtypes and their association...
Autores principales: | Tian, Ye, Zhang, Jingjing, Li, Mingyue, Shang, Jie, Bai, Xiaohong, Zhang, Huijuan, Wang, Yanxia, Chen, Haitao, Song, Xueru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102484/ https://www.ncbi.nlm.nih.gov/pubmed/37065734 http://dx.doi.org/10.3389/fendo.2023.1077590 |
Ejemplares similares
-
Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019) -
Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021) -
Differences in metabonomic profiles of abdominal subcutaneous adipose tissue in women with polycystic ovary syndrome
por: Di, Fangfang, et al.
Publicado: (2023) -
Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome
por: Zhang, Haolin, et al.
Publicado: (2023) -
Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome
por: Wang, Siyu, et al.
Publicado: (2022)